Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Search

Astellas Pharma Inc.

Hong Kong
  • About
    • Business Philosophy
    • Vision & Strategy
    • Astellas Group Code of Conduct
    • Policies & Position Statements
    • History
      • Astellas Hong Kong
    • Compliance Initiatives
    • President and CEO’s Message
    • Product Introductions
    Recommended
    Astellas Hong Kong

    The Company was established in 1995 with the name of Fujisawa Hong Kong, Ltd., a wholly-owned subsidiary of Fujisawa Taiwan Co., Ltd.

    Read More
  • Innovation
    • R&D
      • Approach
      • Clinical Trials
      • Ethics & Principles
      • Pipeline
    • Partnering
    Recommended
    Clinical Trials

    This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any...

    Read More
  • Responsibility
    • CSR-Based Management
    • CSR Activities in Five Fields
      • Business Activities
      • Society
      • Environment
      • Employees
        • Development and Training
      • Ethics & Compliance
    • Company Awards
    Recommended
    Company Awards

    To demonstrate our commitment to be the company of choice among our stakeholders, Astellas Pharma Hong Kong Company Limited applied for and...

    Read More
  • News
    • News
    • Stories
    Recommended
    Stories

    The “Story” section contains contents focused on “hero”: people (patients, employees, scientists, etc.), scientific innovation and social...

    Read More

Stakeholders menu

  • Products
  • Contact Us

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  • HONG KONG
  • WORLDWIDE - HONG KONG
  • English
  • 中文
Important Notice

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

I Agree
logo
Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Cancel Click here to leave this site.
Previous Pause Next
Vision & Strategy Vision & Strategy

On the forefront of healthcare change to turn innovative science into value for patients

Read More
Development and Training Development and Training

Astellas has defined its aspirations for its human resources and organizational capabilities

Read More
R&D R&D

Our commitment to R&D is based on the development of medical solutions that address medical needs in our disease areas for research

Read More
1
2
3

News

  • Latest
  • Media
  • IR
  • CSR
  • Stories
Global
最新消息 / Media
Apr 26, 2018
Astellas Reports Financial Results for FY2017
Read More
Global
最新消息 / IR
Jan 31, 2018
Astellas Reports Financial Results for the First Nine Months of FY2017
Read More
Global
最新消息 / Stories
Oct 26, 2016
Astellas Uses C3 Prize to Look Beyond Treatments in Fostering Innovation in Cancer Care
Read More
View more >>
Global
最新消息 / Media
Apr 26, 2018
Astellas Reports Financial Results for FY2017
Read More
View more >>
Global
最新消息 / IR
Jan 31, 2018
Astellas Reports Financial Results for the First Nine Months of FY2017
Read More
View more >>
View more >>
Global
最新消息 / Stories
Oct 26, 2016
Astellas Uses C3 Prize to Look Beyond Treatments in Fostering Innovation in Cancer Care
Read More
Global
最新消息 / Stories
Oct 24, 2016
Local Contribution. Global Impact.
Read More
Global
最新消息 / Stories
Oct 28, 2015
Fit for Today, Fit for Tomorrow, Fit for Life!
Read More
View more >>

Homepage External Link

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • ACCESSIBILITY
  • TERMS OF USE
  • CONTACT US
Copyright © 2017 Astellas Pharma Inc. All right Reserved.